Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

ClinicalTrials.gov ID: NCT01017627

Public ClinicalTrials.gov record NCT01017627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Case Controlled Study to Determine the Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in ESRD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization. Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.

Study identification

NCT ID
NCT01017627
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Enrollment
1,500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Oct 31, 2010
Completion
Nov 30, 2010
Last update posted
Apr 1, 2010

2009 – 2010

United States locations

U.S. sites
42
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Denver Central Denver Colorado 80209
St. John's Jacksonville Florida 32246
JAX Beach Jacksonville Florida 32250
Prairie Chicago Illinois 60616
Tri Counties Decatur Indiana 46733
Huntington Huntington Indiana 46750
Floyd County New Albany Indiana 47150
South Louisville Louisville Kentucky 40216
Breaux Bridge Breaux Bridge Louisiana 70517
Delta Delta Louisiana 71233
East Lafayette Lafayette Louisiana 70501
Methuen Methuen Massachusetts 01844
Roxbury Roxbury Massachusetts 02119
Battle Creek Battle Creek Michigan 49014
East Lansing East Lansing Michigan 48823
Oshtemo Kalamazoo Michigan 49009
Lansing Lansing Michigan 48911
Saganaw Riverside Saginaw Michigan 48602
Saginaw Saginaw Michigan 48602
Eupora Eupora Mississippi 39744
Meridian Meridian Mississippi 39301
Yokna River Oxford Mississippi 38655
Independence Centerpoint Independence Missouri 64057
Desert Inn Las Vegas Nevada 89109
South Pecos Las Vegas Nevada 89120
Briggs Ave Durham North Carolina 27703
Freedom Lake Durham North Carolina 27704
Boardman Boardman Ohio 44512
Cortland Cortland Ohio 44410
Elyria Elyria Ohio 44035
North Randall North Randall Ohio 44128
Westlake Westlake Ohio 44145
Willoughby Willoughby Ohio 44094
Twin Oaks Beaverton Oregon 97006
Clackamas Clackamas Oregon 97015
Fresenius Medical Services Brentwood Tennessee 37027
Smyrna Smyrna Tennessee 37167
West Nashville West Nashville Tennessee 37209
North Fort Worth Fort Worth Texas 76119
Tarrant County Fort Worth Texas 76119
Waco Waco Texas 76708
Waco West Waco Texas 76712

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01017627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2010 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01017627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →